Presentation Information
[1-FP7-5]日本のEGUIDE参加施設における治療抵抗性統合失調症の有病率とクロザピン治療率：全国多施設共同研究
Yusuke Arai1, Hiroyuki Muraoka2, Kazuhiko Yamamuro4, Yuka Yasuda3,5, Toshinori Nakamura1, Shinichiro Ochi6, Hirotaka Yamagata3, Toru Horinouchi7, Yasushi Kawamata8, Keisuke Mori3, Kazutaka Ohi9, Hashimoto Naoki7, Junichi Iga6, Matsumoto Junya3, Ken Inada2, Hikaru Hori10, Norio Furukori8, Ryota Hashimoto3 (1.Department of Psychiatry, Shinshu University School of Medicine, 2.Department of Psychiatry, Kitasato University, School of Medicine, 3.Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, 4.Center for Health Control, Nara Medical University, 5.Life Grow Brilliant Mental Clinic, Medical Corporation Foster, 6.Department of Neuropsychiatry, Molecules and Function, Ehime University Graduate School of Medicine, 7.Department of Psychiatry, Hokkaido University Graduate School of Medicine, 8.Department of Psychiatry, Dokkyo Medical University School of Medicine, 9.Department of Psychiatry, Gifu University Graduate School of Medicine, 10.Department of Psychiatry, Faculty of Medicine, Fukuoka University)